Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

IGC Pharma (IGC) Receivables - Other (2016 - 2025)

IGC Pharma has reported Receivables - Other over the past 15 years, most recently at $670000.0 for Q3 2025.

  • Quarterly Receivables - Other fell 2.19% to $670000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $670000.0 through Sep 2025, down 2.19% year-over-year, with the annual reading at $680000.0 for FY2025, 0.87% down from the prior year.
  • Receivables - Other was $670000.0 for Q3 2025 at IGC Pharma, down from $680000.0 in the prior quarter.
  • Over five years, Receivables - Other peaked at $951000.0 in Q1 2023 and troughed at $354000.0 in Q2 2022.
  • The 5-year median for Receivables - Other is $680000.0 (2025), against an average of $647368.4.
  • Year-over-year, Receivables - Other skyrocketed 168.64% in 2023 and then decreased 28.22% in 2024.
  • A 5-year view of Receivables - Other shows it stood at $382000.0 in 2021, then surged by 96.6% to $751000.0 in 2022, then grew by 25.97% to $946000.0 in 2023, then decreased by 28.22% to $679000.0 in 2024, then fell by 1.33% to $670000.0 in 2025.
  • Per Business Quant, the three most recent readings for IGC's Receivables - Other are $670000.0 (Q3 2025), $680000.0 (Q2 2025), and $680000.0 (Q1 2025).